There are very long lead times to bring medical discoveries in the pharmaceutical arena to a point where commercial opportunities can be realised. A major focus of the ACMD will be the fabrication of medical devices which have a much shorter lead time from development to market.
The ACMD will reduce operational expenditure and increase staff and capital efficiencies with shared laboratory support, IT infrastructure, technical support platform technologies and flexible laboratory designs all contributing to these efficiencies.
a window of opportunity exists to maximise the impact of the ACMD on the biomedical engineering landscape. it is critical that we develop the ACMD now